Prof. Ahmet Bilici is one of Turkey's leading specialists in sarcoma and lung cancer, with over 20 years of oncology experience.
1,100+ lung cancer treatments performed – Dr. Ozadli specializes in oncology at Valued Med Hub Hospitals.
Specializes in lung cancer research and treatment, with publications on prognostic factors like mean platelet volume.
Dr. Turkan Ozturk Topcu specializes in lung cancer and other advanced oncology cases, with training at MD Anderson and Sunnybrook Odette Cancer Center.
Professor Ondzhel is a board-certified oncosurgeon and an official Fellow of the American Society of Colorectal Surgeons, leading the surgery department at Medipol.
Prof. Dr. Özcan Yıldız is a medical oncologist with extensive experience treating complex cancer cases at Medipol Mega University Hospital.
Prof. Dr. Mehmet Zeki Gunluoglu brings expertise in thoracic surgery to Medipol Mega University Hospital.
Prof. Didem Tastekin specializes in lung cancer at Istanbul University Oncology Institute, one of Turkey's leading cancer centers.
Assoc. Prof. Dr. Tahsin Ozatli specializes in lung cancer at Istinye University Liv Hospital Bahcesehir.
Leading lung cancer specialist Prof. Cemil Bilir holds memberships in ASCO, ESMO, and TTOD – key oncology organizations.
Dr. Ozden specializes in medical oncology with a focus on lung cancer, bringing expertise from training at Istanbul University and Kocaeli University.
Prof. Paksoy specializes in lung cancer at Medipol Bahcelievler Hospital, with extensive research in NSCLC treatments like ALK-positive and ROS1 fusion cases.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Specializes in thoracic surgical oncology with expertise in VATS (Video Assisted Thoracoscopic Surgery) for lung cancer at Medical Park Göztepe Hospital Complex.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Associate Professor Dr. Serap Kaya specializes in lung cancer treatment at Emsey Hospital.
Professor Adnansayar specializes in thoracoscopic and robotic minimally invasive lung surgery, working at Liv Hospital Vadistanbul – Turkey's premier healthcare facility.